Financial Security Advisor’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$265K Sell
4,362
-87
-2% -$5.07K 0.05% 136
2025
Q4
$240K Sell
4,449
-315
-7% -$15.2K 0.05% 139
2025
Q3
$215K Buy
4,764
+23
+0.5% +$1.07K 0.05% 134
2025
Q2
$219K Buy
4,741
+335
+8% +$16.4K 0.05% 119
2025
Q1
$269K Buy
4,406
+28
+0.6% +$1.63K 0.07% 95
2024
Q4
$248K Buy
4,378
+107
+3% +$5.98K 0.06% 98
2024
Q3
$221K Buy
+4,271
New +$200K 0.06% 105
2024
Q2
Sell
-4,439
Closed -$241K 114
2024
Q1
$241K Buy
4,439
+141
+3% +$7.18K 0.08% 91
2023
Q4
$221K Sell
4,298
-19
-0.4% -$997 0.09% 90
2023
Q3
$251K Buy
+4,317
New +$265K 0.12% 82

Other funds holding BMY

Financial Security Advisor's BMY Position: Q1 2026 in Review

Financial Security Advisor reduced its Bristol-Myers Squibb (BMY) stake by 2% in Q1 2026, selling an estimated $5.07K and leaving 4,362 shares worth $265K. The position accounts for 0.05% of the portfolio, ranked #136.

Financial Security Advisor first reported a position in BMY in Q3 2023 and has held it in 10 quarters since. The position peaked at $269K in Q1 2025. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Financial Security Advisor held 4,362 shares of Bristol-Myers Squibb worth $265K as of Q1 2026.
  • Financial Security Advisor sold 87 Bristol-Myers Squibb shares in Q1 2026, an estimated $5.07K.
  • Bristol-Myers Squibb made up 0.05% of Financial Security Advisor's portfolio in Q1 2026, its #136 holding.
  • Financial Security Advisor first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 10 quarters since.
  • Financial Security Advisor's Bristol-Myers Squibb position peaked at $269K in Q1 2025.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Financial Security Advisor's 13F filing for Q1 2026, filed 4 May 2026.